4

FORM 4 SUBMISSION

Company: ORAMED PHARMACEUTICALS INC.
Filed: January 30, 2024
Period of Report: January 30, 2024
Accession Number: 0001209191-24-002429

View Document ↗ View on SEC.gov ↗